1 Result(s)

Article

Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: a case report

Denosumab and abiraterone were approved by the United States Food and Drug Administration in 2011 for the treatment of metastatic castration-resistant prostate cancer. Neither denosumab nor abiraterone is know...

Javier A. Neyra, Natalia A. Rocha, Rhea Bhargava, Omkar U. Vaidya… in BMC Nephrology (2015)